This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovations of Ryota Azuma
Introduction
Ryota Azuma is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approaches to drug stabilization.
Latest Patents
Azuma holds a patent for a stabilized pharmaceutical composition. This composition includes 5-{[(3R)-1-acryloylpyrrolidin-3-yl]oxy}-6-ethyl-3-({4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-pyrazine-2-carboxamide, referred to as 'compound A', or a pharmaceutically acceptable salt thereof. The composition is designed to be stabilized by incorporating a pharmaceutical additive that has a difference in water activity value of 0.1 or more.
Career Highlights
Ryota Azuma is currently employed at Astellas Pharma GmbH, where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation and stabilization has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Azuma collaborates with several esteemed colleagues, including Daisuke Tsunashima and Mitsuru Yoshida. Their combined efforts contribute to advancing pharmaceutical research and development.
Conclusion
Ryota Azuma's work in pharmaceutical innovation exemplifies the importance of stability in drug formulations. His contributions are paving the way for more effective and reliable pharmaceutical compositions.